Amgen Inc (AMGN)
Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell
$463.74
Buy
$464.01
$3.32 (+0.72%)
Prices updated at 09 Nov 2026, 19:09 EST
| Prices minimum 15 mins delay
Prices in USD
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first c ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
| $466.54 - $454.46 | |
| $483.99 - $312.39 | |
| 2.13 | |
| 249,046.47m | |
| 26.69 | |
| - | |
| 865,063 | |
| 17.35 | |
| 2,796,444.00 | |
| -0.01 | |
| 538.80m | |
| US0311621009 | |
| 14.23 | |
| - |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.